BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25658016)

  • 1. Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies.
    Pappachan JM; Raskauskiene D; Kutty VR; Clayton RN
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1405-11. PubMed ID: 25658016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall and cause-specific mortality in GH-deficient adults on GH replacement.
    Gaillard RC; Mattsson AF; Akerblad AC; Bengtsson BÅ; Cara J; Feldt-Rasmussen U; Koltowska-Häggström M; Monson JP; Saller B; Wilton P; Abs R
    Eur J Endocrinol; 2012 Jun; 166(6):1069-77. PubMed ID: 22457236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.
    Svensson J; Bengtsson BA; Rosén T; Odén A; Johannsson G
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3306-12. PubMed ID: 15240607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess mortality in women with pituitary disease: a meta-analysis.
    Nielsen EH; Lindholm J; Laurberg P
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):693-7. PubMed ID: 17634076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing the safety of GH replacement therapy in adults.
    Stochholm K; Johannsson G
    Growth Horm IGF Res; 2015 Aug; 25(4):149-57. PubMed ID: 26117668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
    Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
    J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
    Ragnar Agnarsson H; Johannsson G; Ragnarsson O
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopituitarism and mortality in pituitary adenoma.
    Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis.
    Widdowson WM; Gibney J
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):787-92. PubMed ID: 19769614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).
    Rosilio M; Blum WF; Edwards DJ; Shavrikova EP; Valle D; Lamberts SW; Erfurth EM; Webb SM; Ross RJ; Chihara K; Henrich G; Herschbach P; Attanasio AF
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1684-93. PubMed ID: 15070931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
    Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
    Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
    Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
    J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
    Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.